Intravascular brachytherapy: A systematic review of its role in reducing restenosis after endovascular treatment in peripheral arterial disease

European Journal of Vascular and Endovascular Surgery

Volumn 24, Issue 5, 2002, Pages 377-382

  Hansrani, M ^a   Overbeck, K ^b   Smout, J ^a   Stansby, G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Intravascular brachytherapy; Myointimal hyperplasia; Peripheral arterial disease; Review

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PROSTAGLANDIN E1; WARFARIN;

ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; BRACHYTHERAPY; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR BRACHYTHERAPY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REVIEW; SUPERFICIAL FEMORAL ARTERY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR PATENCY; HYPERPLASIA; INTIMA; METHODOLOGY; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RECURRENT DISEASE; STENT;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BRACHYTHERAPY; HUMANS; HYPERPLASIA; PERIPHERAL VASCULAR DISEASES; RECURRENCE; STENTS; TUNICA INTIMA;

EID: 0036831407     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1742     Document Type: Review

References (49)

1. CLOWES AW, REIDY MA, CLOWES MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49: 208-215.
2. SZILAGYI DE, ELLIOTT JP, HAGEMAN JH, SMITH RF, DALL'OLMO CA. Biological fate of autogenous vein implants as arterial substitutes. Ann Surg 1973; 178: 232-244.
3. DILLEY RJ, MCGEACHIE JK, PRENDERGAST FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia. Arch Surg 1988; 123: 691-696.
4. SOTTIURAI VS, YAO JS, FLINN WR, BATSON RC. Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in humans. Surgery 1983; 93: 809-817.
5. GLAGOV S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation 1994; 89: 2888-2891.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
7. POSTON RN, JOHNSON-TIDEY RR. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: implications for atherogenesis. Am J Pathol 1996; 149: 73-80.
8. CLOWES AW, REIDY MA. Mechanisms of arterial graft failure: the role of cellular proliferation. Ann N Y Acad Sci 1987; 516: 673-678.
9. Anonymous. Management of Peripheral Arterial Disease (PAD): TransAtlantic Inter-society Consensus (TASC). J Vasc Surg 2000; 31: S97-S111.
10. RUTHERFORD R, DURHAM J, KUMPE D, eds. Endovascular Intervention for Lower Extremity Ischaemia. 4th edn. Philadelphia: WB Saunders, 1995.
11. Do DD, TRILLER J, WALPOTH BH, STIRNEMANN P, MAHLER FA. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol 1992; 15: 306-312.
12. HALL E. Radiobiology for the Radiologists. 4th edn. Philadelphia: JB Lippincott Company, 1994.
13. FISCHER-DZOGA K, DIMITRIEVICH GS, GRIEM ML. Radiosensitivity of vascular tissue. II. Differential radiosensitivity of aortic cells in vitro. Radiat Res 1984; 99: 536-546.
14. WILCOX JN, WAKSMAN R, KING SB, SCOTT NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys 1996; 36: 789-796.
15. BOTTCHER HD, SCHOPOHL B. [Endovascular Ir-192 HDR brachytherapy for avoidance of intimal hyperplasia in peripheral vessels after PTA and stent implantation. A 6-year experience]. Strahlentherapie und Onkologie 1998; 174: 115-120.
16. LIERMANN D, BERKEFELD J, HERRMANN G et al. Interventional treatment and clinics in combination with prophylactic endovascular radiation in the therapy of intimal hyperplasia. Radiologe 1994; 34: 524-533.
17. LIERMANN D, BOTTCHER HD, KOLLATH J et al. Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol 1994; 17: 12-16.
18. LIERMANN D, BERKEFELD J, HERRMANN G et al. [Intervention and clinical aspects combined with endovascular irradiation of intimal hyperplasia of the vascular system]. Radiologe 1994; 34: 524-533.
19. LIERMANN DD, BAUERNSACHS R, SCHOPOHL B, BOTTCHER HD. Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Intervent Cardiol 1997; 2: 133-137.
20. LIERMANN D, KIRCHNER J, BAUERNSACHS R, SCHOPOHL B, BOTTCHER HD. Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update. Herz 1998; 23: 394-400.
21. MINAR E, POKRAJAC B, AHMADI R et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology 1998; 208: 173-179.
22. MINAR E, POKRAJAC B, MACA T et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000; 102: 2694-2699.
23. PICHLER LJ, HAWLICZEK R, ANZBOCK W et al. Endoluminal high-dose-rate (HDR) brachytherapy following PTA of the superficial femoral artery and poplitea irradiation. A pilot study. Gefasschirurgie 1999; 4: 153-157.
24. PICHLER LJ, HAWLICZEK R, SOMLOI A, MAYRHOFER R, SCHMIDT WF, HRUBY W. [Endovascular brachytherapy for the prevention of recurrence after PTA]. Radiologe 1999; 39: 118-124.
25. POKRAJAC B, POTTER R, MACA T et al. Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 2000; 48: 923-931.
26. SCHOPOHL B, LIERMANN D, POHLIT LJ et al. 192Ir endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. Int J Radiat Oncol Biol Phys 1996; 36: 835-840.
27. WAKSMAN R, LAIRD JR, JURKOVITZ CT et al. Peripheral Artery Radiation Investigational Study I. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Intern Radiol 2001; 12: 915-921.
28. WOLFRAM RM, POKRAJAC B, AHMADI R et al. Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. Radiology 2001; 220: 724-729.
29. KAY IP, WARDEH AJ, KOZUMA K et al. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia. Circulation 2001; 103: 14-17.
30. KAY IP, WARDEH AJ, KOZUMA K et al. The pattern of restenosis and vascular remodelling after cold-end radioactive stent implantation. Eur Heart J 2001; 22: 1311-1317.
31. MINTZ GS, WEISSMAN NJ, FITZGERALD PJ. Intravascular ultrasound assessment of the mechanisms and results of brachytherapy. Circulation 2001; 104: 1320-1325.
32. HEHRLEIN C, KUBLER W. Advantages and limitations of radioactive stents. Semin Interv Cardiol 1997; 2: 109-113.
33. WARDEH AJ, KNOOK AHM, KAY IP et al. Clinical and angiographic follow-up after implantation of a 6-12 microCi radioactive stent in patients with coronary artery disease. Eur Heart J 2001; 22: 669-675.
34. LEVY DS, SALTER MM, ROTH RE. Postoperative irradiation in the prevention of keloids. Am J Roentgenol 1981; 127: 509-510.
35. NATH R, AMOIS H, COFFEY C et al. Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 60. Med Phys 1999; 26: 119-152.
36. SALAME M, LAMPKIN J, MULKEY P et al. Effects of endovascular irradiation on platelet recruitment at the site of balloon angioplasty in pig coronary arteries. J Am Coll Cardiol 1999: 44A.
37. VODOVOTZ Y, BHARGAVA B, COLLINS SD, CHAN RC, WAKSMAN R. Endovascular Radiation Increases Thrombosis Rate with Decreased Luminal Thrombi and Thrombus Area. Washington, 1999.
38. HEHRLEIN C, GOLLAN C, DONGES K. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995; 92: 1570-1575.
39. HEHRLEIN C, STINTZ M, KINSCHERF R et al. Pure beta-particle-emitting stents inhibit neointima formation in rabbits. Circulation 1996; 93: 641-645.
40. TEIRSTEIN PS, MASSULLO V, JANI S et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000; 101: 360-365.
41. LEON MB, TEIRSTEIN PS, MOSES JW et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344: 250-256.
42. WAKSMAN R, BHARGAVA B, LEON MB. Late thrombosis following intracoronary brachytherapy. Catheter Cardiovasc Interv 2000; 49: 344-347.
43. COSTA MA, SABAT M, VAN DER GIESSEN WJ et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100: 789-792.
44. SAPIERSTEIN W, ZUCKERMAN B, DILLARD J. FDA approval of coronary artery brachytherapy. N Engl J Med 2001; 344: 297-299.
45. ALBIERO R, NISHIDA T, ADAMIAN M et al. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Circulation 2000; 101: 2454-2457.
46. SABATE M, SERRUYS PW, VAN DER GIESSEN WJ et al. Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: a three-dimensional intravascular ultrasound study. Circulation 1999; 100: 1182-1188.
47. CONDADO JA, WAKSMAN R, GURDIEL O et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-732.
48. CONDADO JA, WAKSMAN R, CALDERAS C, SAUCEDO J, LANSKY A. Two-year follow-up after intracoronary gamma radiation therapy. Cardiovasc Radiat Med 1999; 1: 30-35.
49. SUZUKI K. Multistep nature of X-ray-induced neoplastic transformation in mammalian cells: genetic alterations and instability. J Radiat Res 1997; 38: 55-63.